Showing 3831-3840 of 4063 results for "".
- Johnson & Johnson Vision to Launch Tecnis Synergy IOL and Showcase Latest Clinical Data at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs-2/2476873/Johnson & Johnson Vision will highlight key clinical data and the latest solutions in its growing portfolio of innovative products designed to improve vision care across generations at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) 2019 Annual Meeting in Paris, Fran
- MicroPulse Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRShttps://modernod.com/news/micropulse-transscleral-laser-therapy-will-be-discussed-in-various-presentations-and-educational-events-at-escrs/2476872/Iridex announced that its patented MicroPulse laser therapy will be featured prominently in research presented at the 2019 European Society of Cataract & Refractive Surgeons (ESCRS) meeting, to be held in Paris, France. MicroPulse Transscleral Laser Therapy (TLT) is a non-incisional, laser-ba
- Rayner Launching RayOne Trifocal Toric at ESCRShttps://modernod.com/news/rayner-launching-rayone-trifocal-toric-at-escrs/2476866/Rayner announced it is launching its RayOne Trifocal Toric fully preloaded IOL at the ESCRS 2019 congress in Paris. With 11% light loss from its patented diffractive design, RayOne Trifocal Toric will give cataract pa
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t
- Staar Surgical Announces EVO ICL Clinical Program for Its 16th Annual Surgical Experts Summit in Parishttps://modernod.com/news/staar-surgical-announces-evo-icl-clinical-program-for-its-16th-annual-surgical-experts-summit-in-paris/2479541/Staar Surgical announced the EVO ICL Clinical Program, which will be presented by ophthalmic surgeons to ophthalmic surgeons at its invitation only Surgical Experts Summit, is expected to be attended by over 250 surgeons and invited clinician guests from 46 countries. The Experts Summit will be h
- NHS England to Fund Novartis’ Gene Therapy Luxturna for Inherited Retinal Diseasehttps://modernod.com/news/nhs-england-to-fund-novartis-gene-therapy-luxturna-for-inherited-retinal-disease/2476855/NHS England announced Wednesday funding for Novartis’ Luxturna (voretigene neparvovec) after agreeing a deal with the company that will provide access to the gene therapy from January 2020. The one-time treatment gained European Commission approval last year for patients with vision loss du
- Staar Surgical Announces Strategic Alliance Agreement with Asian Eye Institutehttps://modernod.com/news/staar-surgical-announces-strategic-alliance-agreement-with-asian-eye-institute/2476850/Staar Surgical Company announced that it has entered a strategic alliance with Asian Eye Institute, an eye care group with nine locations in the Philippines. Asian Eye Institute was founded in 2001 and has 18 medical doctors, two specialist optometrists, and more than 30 staff optometrists on sta
- Sight Sciences Raises $56M to Lead the Development of MIGS Market and Procedure-Based Dry Eye Markethttps://modernod.com/news/sight-sciences-raises-56m-to-lead-the-development-of-migs-market-and-procedure-based-dry-eye-market/2476848/Sight Sciences announced the closing of $31 million in Series D Preferred Stock financing. MidCap Financial and Sight Sciences entered into a $25 million debt facility earlier in 2019. The $56 million
- Alimera Sciences Launches Iluvien in Germany For Noninfectious Uveitishttps://modernod.com/news/alimera-sciences-launches-iluvien-in-germany-for-noninfectious-uveitis/2476846/Alimera Sciences announced that it will immediately commence the launch of Iluvien in Germany for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye (NIPU). Following the European Union’s Mutual Recognition Procedure in March 2019, Germany is t
- Oxurion to Make a Late-Breaker Presentation of Topline THR-149 Phase 1 Clinical Data at EURETINAhttps://modernod.com/news/oxurion-to-make-a-late-breaker-presentation-of-topline-thr-149-phase-1-clinical-data-at-euretina/2476844/Oxurion NV announced that it will make a late breaking presentation covering the data from its positive phase 1 clinical study with THR-149, a potent plasma kallikrein inhibitor, in patients with diabetic macular edema (DME) at the 19th European Society of Retina Specialists (EURETINA) 2019 Congr